1-Ethyl-2-(7-(1-ethyl-3,3-dimethylindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-3,3-dimethyl-3H-indol-1-ium iodide

Catalog No. :
ACFLJX572
CAS No. :
17094-17-6
Molecular Formula :
C31H37IN2
Molecular Weight :
564.55

IUPAC Name:1-ethyl-2-((1E,3E,5E)-7-((E)-1-ethyl-3,3-dimethylindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-3,3-dimethyl-3H-indol-1-ium iodide

1-Ethyl-2-(7-(1-ethyl-3,3-dimethylindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-3,3-dimethyl-3H-indol-1-ium iodide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$360.00Login to see priceInquiryInquiry
250mg97%$1082.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Ethyl-2-(7-(1-ethyl-3,3-dimethylindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-3,3-dimethyl-3H-indol-1-ium iodide
IUPAC Name1-ethyl-2-((1E,3E,5E)-7-((E)-1-ethyl-3,3-dimethylindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-3,3-dimethyl-3H-indol-1-ium iodide
Molecular FormulaC31H37IN2
Molecular Weight564.55
SMILESCC1(C)C(/C=C/C=C/C=C/C=C2N(CC)C3=C(C=CC=C3)C\2(C)C)=[N+](CC)C4=C1C=CC=C4.[I-]
InChI KeyMOCQTYXDGSDJGM-UHFFFAOYSA-M
SynonymCy7 Di Et;lipo Cy7(Et)2;1-Ethyl-2-(7-(1-ethyl-3,3-dimethylindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-3,3-dimethyl-3H-indol-1-ium iodide
CAS No.17094-17-6

Synthetic Route by SureRoute

1. ACFLJX572 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFLJX572 route product structure diagram
    ACFLJX57217094-17-6
Inquiry

2. ACFLJX572 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFLJX572 route product structure diagram
    ACFLJX57217094-17-6
Inquiry

Comments (0)